Biotech
> PharmaCyte Biotech appoints Thomas Liquard, formerly of Pfizer ($PFE) and Alchemia (ASX:ACL), to its board of directors. Release
> Merck KGaA names Alise Reicin as head of global clinical development at Merck Serono. Release
> Shlomo Yanai joins Sagent Pharma's ($SGNT) board of directors. Release
> TxCell adds Dr. David Solomon to its board of directors. He will also serve as chair of the Remuneration and Nominations subcommittee. Release
> Orgenesis appoints Chris Buyse to its board of directors. Release
> MaSTherCell CEO Hugues Bultot joins Orgenesis' board of directors. Release
> Sagent Pharma ($SGNT) appoints Michael Logerfo as president. Release
> Ovid Therapeutics names former Teva ($TEVA) CEO Jeremy Levin as CEO. Release | Story
> Ironwood Pharma ($IRWD) adds Dr. Lawrence Olanoff to its board of directors and to its pharmaceutical advisory committee. Release
> Allena Pharma appoints Dr. Louis Brenner as chief operating officer. Release
> Celgene ($CELG) adds former Cubist CEO Michael Bonney to its board of directors. Release
> Adamis ($ADMP) appoints Gus Fernandez as vice president of commercial operations, Louis Fayant as director of account management and David DeLay as senior national accounts manager for alternative markets. Release
> Strand Life Sciences appointed Scott Storrer as global president. Release
> Jennifer Saputo joins Astellas as associate director of employee communications. Release
> Eric Green joins West Pharma ($WST) as CEO. Release
> Tetraphase Pharma ($TTPH) appoints Gerri Henwood to its board of directors. Release
> Zoetis ($ZTS) appointed Paul Bisaro to its board of directors. Release
> Gregory Sieczkiewicz joined MPM Capital as its managing director and chief counsel of intellectual property. Release
> CAPNIA appointed Edward Ebbers as its chief commercial officer. Release
> Phlexglobal named Rick Riegel as its CEO. Release
> Halozyme ($HALO) appointed Harry Leonhardt as its senior vice president, general counsel and chief compliance officer. Release
> Egalet appointed Nicholas Nicolaides and John Osborn to its board of directors. Release
> Axsome appointed Dr. Randall Kaye as its chief medical officer. Release (PDF)
Med tech
> OMNIlife science names Steven Nunes as senior vice president of sales and marketing. Release
Vaccines
> Vaxin named Elizabeth Adkins Czerepak its chief financial officer. Release
|